Deciphering the Underlying Mechanism of Eucommiae Cortex Against Osteoporotic Fracture by Network Pharmacology

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2020 Sep 23

PMID 32963568

Citations 6

Authors

Yongming Shuai

Zhili Jiang

Qiuwen Yuan

Shuqiang Tu

Fanhui Zeng

Affiliations

Soon will be listed here.

Abstract

Background: Du Zhong (DZ), or Eucommiae Cortex, a traditional Chinese herbal medicine, has been used to treat osteoporosis. Although it has been reported that DZ can improve bone mass in ovariectomized rats, its pharmacological mechanisms in treating osteoporotic fractures (OPF) remain unclear.

Methods: In this study, we used a network pharmacological manner to explore its potential complicated mechanism in treating OPF. We obtained DZ compounds from TCMSP and BATMAN-TCM databases and collected potential targets of these compounds through target fishing based on TCMSP and BATMAN-TCM databases. Next, we collected the OPF targets by using CTD, GeneCards, OMIM, HPO, and GenCLiP 3 databases. And then the overlapping genes between DZ potential targets and OPF targets were used to build up the protein-protein interaction (PPI) network and to analyze their interactions and find out the big hub genes in this network. Subsequently, clusterProfiler package in language was utilized to conduct the enrichment of Gene Ontology biological process and KEGG pathways.

Results: There were totally 93 active compounds and 916 related targets in DZ. After the enrichment analysis, we collected top 25 cellular biological processes and top 25 pathways based on the adjusted value and found that the DZ anti-OPF effect was mainly associated with the regulation of ROS and inflammatory response. Furthermore, 64 hub genes in PPI network, such as MAPK1 (degree = 41), SRC (degree = 39), PIK3R1 (degree = 36), VEGFA (degree = 31), TP53 (degree = 29), EGFR (degree = 29), JUN (degree = 29), AGT (degree = 29), MAPK1, SRC, PIK3R1, VEGFA, and TP53, were considered as potential therapeutic targets, implying the underlying mechanisms of DZ acting on OPF.

Conclusion: We investigated the possible therapeutic mechanisms of DZ from a systemic perspective. These key targets and pathways provided promising directions for the future research to reveal the exact regulating mechanisms of DZ in treating OPF.

Citing Articles

Unraveling the potential mechanisms of the anti-osteoporotic effects of the herb pair: a network pharmacology and experimental study.

Li T, Li W, Guo X, Tan T, Xiang C, Ouyang Z Front Pharmacol. 2023; 14:1242194.

PMID: 37849727 PMC: 10577322. DOI: 10.3389/fphar.2023.1242194.

Exploring the pharmacological mechanism of Duhuo Jisheng Decoction in treating intervertebral disc degeneration based on network pharmacology.

Song C, Chen R, Cheng K, Zhou D, Mei Y, Yan J Medicine (Baltimore). 2023; 102(22):e33917.

PMID: 37266623 PMC: 10238016. DOI: 10.1097/MD.0000000000033917.

Mechanism Investigation of Wuwei Shexiang Pills on Gouty Arthritis via Network Pharmacology, Molecule Docking, and Pharmacological Verification.

Lang J, Li L, Chen S, Quan Y, Yi J, Zeng J Evid Based Complement Alternat Med. 2022; 2022:2377692.

PMID: 36248423 PMC: 9568303. DOI: 10.1155/2022/2377692.

Identification of kaempferol as an OSX upregulator by network pharmacology-based analysis of qianggu Capsule for osteoporosis.

Huang A, Xiong Z, Liu K, Chang Y, Shu L, Gao G Front Pharmacol. 2022; 13:1011561.

PMID: 36210811 PMC: 9539404. DOI: 10.3389/fphar.2022.1011561.

Overexpression of PIK3R1 Promotes Bone Formation by Regulating Osteoblast Differentiation and Osteoclast Formation.

Zhu H, Chen H, Ding D, Wang S, Dai X, Zhu Y Comput Math Methods Med. 2021; 2021:2909454.

PMID: 34691235 PMC: 8531831. DOI: 10.1155/2021/2909454.

References

Li P, Yang L, Gong Y . Application of systems biology technology in research of traditional Chinese medicine. J Tradit Chin Med. 2009; 29(2):153-7. DOI: 10.1016/s0254-6272(09)60054-6. View

Tong Y, Feng W, Wu Y, Lv H, Jia Y, Jiang D . Mechano-growth factor accelerates the proliferation and osteogenic differentiation of rabbit mesenchymal stem cells through the PI3K/AKT pathway. BMC Biochem. 2015; 16:1. PMC: 4299473. DOI: 10.1186/s12858-015-0031-z. View

Gertz E, Silverman N, Wise K, HANSON K, Alekel D, Stewart J . Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation. J Clin Densitom. 2010; 13(3):277-82. PMC: 2912969. DOI: 10.1016/j.jocd.2010.04.003. View

Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D . GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support. Bioinformatics. 1998; 14(8):656-64. DOI: 10.1093/bioinformatics/14.8.656. View

Watkins B, Lippman H, Le Bouteiller L, Li Y, Seifert M . Bioactive fatty acids: role in bone biology and bone cell function. Prog Lipid Res. 2001; 40(1-2):125-48. DOI: 10.1016/s0163-7827(00)00016-3. View

Domazetovic V, Marcucci G, Iantomasi T, Brandi M, Vincenzini M . Oxidative stress in bone remodeling: role of antioxidants. Clin Cases Miner Bone Metab. 2017; 14(2):209-216. PMC: 5726212. DOI: 10.11138/ccmbm/2017.14.1.209. View

Clynes M, Harvey N, Curtis E, Fuggle N, Dennison E, Cooper C . The epidemiology of osteoporosis. Br Med Bull. 2020; 133(1):105-117. PMC: 7115830. DOI: 10.1093/bmb/ldaa005. View

Savaridas T, Wallace R, Salter D, Simpson A . Do bisphosphonates inhibit direct fracture healing?: A laboratory investigation using an animal model. Bone Joint J. 2013; 95-B(9):1263-8. DOI: 10.1302/0301-620X.95B9.31562. View

Lewiecki E, Ortendahl J, Vanderpuye-Orgle J, Grauer A, Arellano J, Lemay J . Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States. JBMR Plus. 2019; 3(9):e10192. PMC: 6808223. DOI: 10.1002/jbm4.10192. View

10.

Ru J, Li P, Wang J, Zhou W, Li B, Huang C . TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014; 6:13. PMC: 4001360. DOI: 10.1186/1758-2946-6-13. View

11.

Mody N, Parhami F, Sarafian T, Demer L . Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med. 2001; 31(4):509-19. DOI: 10.1016/s0891-5849(01)00610-4. View

12.

An Y, Zhang H, Wang C, Jiao F, Xu H, Wang X . Activation of ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis. FASEB J. 2019; 33(11):12515-12527. PMC: 6902677. DOI: 10.1096/fj.201802805RR. View

13.

Robinson P, Kohler S, Bauer S, Seelow D, Horn D, Mundlos S . The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. Am J Hum Genet. 2008; 83(5):610-5. PMC: 2668030. DOI: 10.1016/j.ajhg.2008.09.017. View

14.

Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y . A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci. 2012; 13(6):6964-6982. PMC: 3397506. DOI: 10.3390/ijms13066964. View

15.

Tang Y, Li M, Wang J, Pan Y, Wu F . CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems. 2014; 127:67-72. DOI: 10.1016/j.biosystems.2014.11.005. View

16.

Kharazmi M, Schilcher J, Hallberg P, Michaelsson K . [Bisphosphonate-associated atypical fractures of the femur: an update of the current evidence]. Lakartidningen. 2019; 116. View

17.

Swanberg M, McGuigan F, Ivaska K, Gerdhem P, Akesson K . Polymorphisms in the inflammatory genes CIITA, CLEC16A and IFNG influence BMD, bone loss and fracture in elderly women. PLoS One. 2012; 7(10):e47964. PMC: 3485004. DOI: 10.1371/journal.pone.0047964. View

18.

Missiuro P, Liu K, Zou L, Ross B, Zhao G, Liu J . Information flow analysis of interactome networks. PLoS Comput Biol. 2009; 5(4):e1000350. PMC: 2685719. DOI: 10.1371/journal.pcbi.1000350. View

19.

Gan X, Huang S, Yu Q, Yu H, Yan S . Blockade of Drp1 rescues oxidative stress-induced osteoblast dysfunction. Biochem Biophys Res Commun. 2015; 468(4):719-25. PMC: 4834976. DOI: 10.1016/j.bbrc.2015.11.022. View

20.

Weitzmann M, Cenci S, Rifas L, Haug J, DiPersio J, Pacifici R . T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms. J Bone Miner Res. 2001; 16(2):328-37. DOI: 10.1359/jbmr.2001.16.2.328. View